These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
69 related items for PubMed ID: 10928041
1. Antitumor effect of IL-2, p53, and bax gene transfer in C6 glioma cells. Haghighat P, Timiryasova TM, Chen B, Kajioka EH, Gridley DS, Fodor I. Anticancer Res; 2000; 20(3A):1337-42. PubMed ID: 10928041 [Abstract] [Full Text] [Related]
2. Evaluation of combined vaccinia virus-mediated antitumor gene therapy with p53, IL-2, and IL-12 in a glioma model. Chen B, Timiryasova TM, Andres ML, Kajioka EH, Dutta-Roy R, Gridley DS, Fodor I. Cancer Gene Ther; 2000 Nov; 7(11):1437-47. PubMed ID: 11129286 [Abstract] [Full Text] [Related]
3. Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models. Wen SF, Xie L, McDonald M, DiGiacomo R, Chang A, Gurnani M, Shi B, Liu S, Indelicato SR, Hutchins B, Nielsen LL. Cancer Gene Ther; 2000 Nov; 7(11):1469-80. PubMed ID: 11129289 [Abstract] [Full Text] [Related]
7. Enhanced apoptosis following treatment with TRA-8 anti-human DR5 monoclonal antibody and overexpression of exogenous Bax in human glioma cells. Kaliberov S, Stackhouse MA, Kaliberova L, Zhou T, Buchsbaum DJ. Gene Ther; 2004 Apr; 11(8):658-67. PubMed ID: 14973547 [Abstract] [Full Text] [Related]
8. In vivo expression and antitumor activity of p53 gene transfer with naked plasmid DNA in an ovarian cancer xenograft model in nude mice. Collinet P, Vereecque R, Sabban F, Vinatier D, Leblanc E, Narducci F, Querleu D, Quesnel B. J Obstet Gynaecol Res; 2006 Oct; 32(5):449-53. PubMed ID: 16984510 [Abstract] [Full Text] [Related]
10. p53 adenoviral vector (Ad-CMV-p53) induced prostatic growth inhibition of primary cultures of human prostate and an experimental rat model. Shirakawa T, Gotoh A, Gardner TA, Kao C, Zhang ZJ, Matsubara S, Wada Y, Hinata N, Fujisawa M, Hanioka K, Matsuo M, Kamidono S. J Gene Med; 2000 Oct; 2(6):426-32. PubMed ID: 11199263 [Abstract] [Full Text] [Related]
15. Prostate-specific expression of Bax delivered by an adenoviral vector induces apoptosis in LNCaP prostate cancer cells. Lowe SL, Rubinchik S, Honda T, McDonnell TJ, Dong JY, Norris JS. Gene Ther; 2001 Sep; 8(18):1363-71. PubMed ID: 11571575 [Abstract] [Full Text] [Related]
16. [Gene therapy with tumor suppressor gene p53 and(or) p16 on the nude mice models of NSCLC in vivo]. Wu W, Zhang X, Qi X. Zhonghua Jie He He Hu Xi Za Zhi; 2000 Jul; 23(7):403-5. PubMed ID: 11778504 [Abstract] [Full Text] [Related]
17. Adenovirus-mediated gene transfer of P16INK4/CDKN2 into bax-negative colon cancer cells induces apoptosis and tumor regression in vivo. Tamm I, Schumacher A, Karawajew L, Ruppert V, Arnold W, Nüssler AK, Neuhaus P, Dörken B, Wolff G. Cancer Gene Ther; 2002 Aug; 9(8):641-50. PubMed ID: 12136424 [Abstract] [Full Text] [Related]
19. hTERT promoter induces tumor-specific Bax gene expression and cell killing in syngenic mouse tumor model and prevents systemic toxicity. Gu J, Andreeff M, Roth JA, Fang B. Gene Ther; 2002 Jan; 9(1):30-7. PubMed ID: 11850720 [Abstract] [Full Text] [Related]
20. Knock-in mice with a chimeric human/murine p53 gene develop normally and show wild-type p53 responses to DNA damaging agents: a new biomedical research tool. Luo JL, Yang Q, Tong WM, Hergenhahn M, Wang ZQ, Hollstein M. Oncogene; 2001 Jan 18; 20(3):320-8. PubMed ID: 11313961 [Abstract] [Full Text] [Related] Page: [Next] [New Search]